Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 1
2003 3
2004 2
2005 1
2006 5
2007 4
2008 4
2009 2
2010 4
2011 3
2012 3
2013 6
2014 5
2015 5
2016 1
2017 3
2018 3
2019 2
2021 1
2022 3
2023 3
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

61 results

Results by year

Filters applied: . Clear all
Page 1
Interleukin-1α.
Rider P, Carmi Y, Voronov E, Apte RN. Rider P, et al. Among authors: voronov e. Semin Immunol. 2013 Dec 15;25(6):430-8. doi: 10.1016/j.smim.2013.10.005. Epub 2013 Nov 1. Semin Immunol. 2013. PMID: 24183701 Review.
Preface.
Voronov E, Apte RN. Voronov E, et al. Cancer Microenviron. 2015 Dec;8(3):123-4. doi: 10.1007/s12307-015-0178-6. Cancer Microenviron. 2015. PMID: 26743884 Free PMC article. No abstract available.
Alarmins: Feel the Stress.
Rider P, Voronov E, Dinarello CA, Apte RN, Cohen I. Rider P, et al. Among authors: voronov e. J Immunol. 2017 Feb 15;198(4):1395-1402. doi: 10.4049/jimmunol.1601342. J Immunol. 2017. PMID: 28167650 Review.
The role IL-1 in tumor-mediated angiogenesis.
Voronov E, Carmi Y, Apte RN. Voronov E, et al. Front Physiol. 2014 Mar 28;5:114. doi: 10.3389/fphys.2014.00114. eCollection 2014. Front Physiol. 2014. PMID: 24734023 Free PMC article. Review.
MEK1/2 inhibition transiently alters the tumor immune microenvironment to enhance immunotherapy efficacy against head and neck cancer.
Prasad M, Zorea J, Jagadeeshan S, Shnerb AB, Mathukkada S, Bouaoud J, Michon L, Novoplansky O, Badarni M, Cohen L, Yegodayev KM, Tzadok S, Rotblat B, Brezina L, Mock A, Karabajakian A, Fayette J, Cohen I, Cooks T, Allon I, Dimitstein O, Joshua B, Kong D, Voronov E, Scaltriti M, Carmi Y, Conde-Lopez C, Hess J, Kurth I, Morris LGT, Saintigny P, Elkabets M. Prasad M, et al. Among authors: voronov e. J Immunother Cancer. 2022 Mar;10(3):e003917. doi: 10.1136/jitc-2021-003917. J Immunother Cancer. 2022. PMID: 35292516 Free PMC article.
61 results